GPC3-directed CAR-T in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
Conditions: Liver Carcinoma; Hepatic Cell Carcinoma Interventions: Biological: CAR-GPC3 T cells Sponsors: Shanghai Ming Ju Biotechnology Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Research | Urology & Nephrology